BOLT vs CTVA · rev $7.7M vs P/E 42, rev $16.91B
Bolt Biotherapeutics (BOLT) versus Corteva Inc (CTVA) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
BOLT currently screens at market cap $11.3M. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Not investment advice. Open the BOLT and CTVA stock pages for the full models.
Not investment advice.